GSK gets Chinese approval for shingles vaccine Shingrix
Shingrix is a non-live and recombinant subunit adjuvanted vaccine, which will be administered intramuscularly in two doses. Shingles is caused by the reactivation of the varicella zoster virus
German company Merck has introduced the first single-use reactor specifically designed for the production of antibody-drug conjugates (ADCs).
This revolutionary platform empowers scientists in the pharmaceutical industry to generate novel drug-like compounds by combining powerful methods for molecule generation, ADMET prediction, and high-throughput ligand-protein interaction prediction.